This information was published on 2025-05-08T06:26:07 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2542457 (IR 1850223) |
| (220) |
09 Apr 2025
|
| (300) |
BX, 20 Nov 2024, 1514618
|
| (500) |
The applicant has advised that the words in the Mark have no meaning in English
|
| (511) (510) |
Class 5
Pharmaceutical and medicinal preparations and substances; vaccines. |
| (540) | FLUVIXGO |
| (550) | Word |
| (730) |
GlaxoSmithKline Biologicals S.A.
|
Find out more about publications on the About page.